C-Peptide Reverses Nociceptive Neuropathy in Type 1 Diabetes

Diabetes - United States
doi 10.2337/db06-0396
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

C-Peptide Persistence in Type 1 Diabetes: ‘Not Drowning, but Waving’?

BMC Medicine
Medicine
2019English

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

Inverse Relationship Between Glomerular Hyperfiltration and C-Peptide Level in Type 1 Diabetes

Journal of Diabetes Mellitus
2014English

Pregnancy-Induced Rise in Serum C-Peptide Concentrations in Women With Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

Amelioration of Sensory Nerve Dysfunction by C-Peptide in Patients With Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Gastrointestinal Motility in People With Type 1 Diabetes and Peripheral Neuropathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy